Health6 days ago
MannKind’s Afrezza Receives FDA Review for Pediatric Diabetes Use
MannKind Corporation has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental marketing application for Afrezza, an inhalation powder of human insulin....
